Application of hypersensitivity C-reative protein to detect neonatal infectious diseases
Guo Rong-min
Abstract
Guo Rong-min
Abstract
Objective:To explore the clinical value of hypersensitiity C-reactive protein(hsCRP) and the relationship between hsCRP content and neonatal infectious diseases.Methods:To detect hsCRP in 212 neonate who were born within two weeks in the department of neonatology in our hospital.Results:In pre-treatment of bacterial infection group(A group) hsCRP content was significantly higher than non-bacterial infection group(B group) and the control group(C group),P0.05,with statistical significance.There was no significant difference between B group and C group.Conclusion:hsCRP can be used as an early important diagnosis indicators of neonatal bacterial infections.Dynamic monitoring hsCRP content can be used as the evidence of healing effect of bacterial infections.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To explore the clinical value of hypersensitiity C-reactive protein(hsCRP) and the relationship between hsCRP content and neonatal infectious diseases.Methods:To detect hsCRP in 212 neonate who were born within two weeks in the department of neonatology in our hospital.Results:In pre-treatment of bacterial infection group(A group) hsCRP content was significantly higher than non-bacterial infection group(B group) and the control group(C group),P0.05,with statistical significance.There was no significant difference between B group and C group.Conclusion:hsCRP can be used as an early important diagnosis indicators of neonatal bacterial infections.Dynamic monitoring hsCRP content can be used as the evidence of healing effect of bacterial infections.
Key concepts: Medicine, C-reactive protein, Neonatology, Group B, Internal medicine, Neonatal infection, Group A, Clinical significance